Literature DB >> 23080026

[Epithelial-mesenchymal transition in non-small cell lung cancer].

A Soltermann1.   

Abstract

Non-small cell lung carcinoma (NSCLC) is a highly fibrotic malignancy, which exhibits a prominent desmoplastic stroma. Epithelial-mesenchymal transition (EMT) is one of the main modes of carcinoma invasion. We identified the stromal N-glycoprotein periostin by mass spectrometry of lung adenocarcinoma pleural effusions. Validation on a NSCLC tissue microarray and on tumor whole sections by immunohistochemistry indicated that periostin is strongly upregulated at the invasive front in both tumor epithelia and the surrounding matricellular space. In comparison to collagen, elastin and vimentin, periostin was found to be most closely associated with parameters of tumor progression such as larger size and higher stage, with the squamous cell histotype, and with decreased survival. An association with decreased survival was also found for the cell adhesion molecule L1CAM. In conclusion, enlargement of NSCLC tumors is associated with an increase of desmoplastic stroma and concomitant upregulation of EMT markers at the invasive front. The tumor-stroma interface may be a candidate topographic region for stroma- or EMT-directed therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23080026     DOI: 10.1007/s00292-012-1635-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  24 in total

1.  Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.

Authors:  Andrew H Beck; Ankur R Sangoi; Samuel Leung; Robert J Marinelli; Torsten O Nielsen; Marc J van de Vijver; Robert B West; Matt van de Rijn; Daphne Koller
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

2.  Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase.

Authors:  Takumi Maruhashi; Isao Kii; Mitsuru Saito; Akira Kudo
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

Review 3.  L1CAM malfunction in the nervous system and human carcinomas.

Authors:  Michael K E Schäfer; Peter Altevogt
Journal:  Cell Mol Life Sci       Date:  2010-03-17       Impact factor: 9.261

4.  Interactions between cancer stem cells and their niche govern metastatic colonization.

Authors:  Ilaria Malanchi; Albert Santamaria-Martínez; Evelyn Susanto; Hong Peng; Hans-Anton Lehr; Jean-Francois Delaloye; Joerg Huelsken
Journal:  Nature       Date:  2011-12-07       Impact factor: 49.962

5.  Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients.

Authors:  Yusuke Takahashi; Genichiro Ishii; Tetsuhiko Taira; Satoshi Fujii; Shinya Yanagi; Tomoyuki Hishida; Junji Yoshida; Mitsuyo Nishimura; Hiroaki Nomori; Kanji Nagai; Atsushi Ochiai
Journal:  J Thorac Oncol       Date:  2011-09       Impact factor: 15.609

Review 6.  Periostin: novel diagnostic and therapeutic target for cancer.

Authors:  Y Kudo; B S M S Siriwardena; H Hatano; I Ogawa; T Takata
Journal:  Histol Histopathol       Date:  2007-10       Impact factor: 2.303

7.  Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.

Authors:  Alex Soltermann; Verena Tischler; Stefanie Arbogast; Julia Braun; Nicole Probst-Hensch; Walter Weder; Holger Moch; Glen Kristiansen
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels.

Authors:  A Palumbo; F Hauler; P Dziunycz; K Schwager; A Soltermann; F Pretto; C Alonso; G F Hofbauer; R W Boyle; D Neri
Journal:  Br J Cancer       Date:  2011-03-08       Impact factor: 7.640

10.  L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.

Authors:  Verena Tischler; Marco Pfeifer; Silke Hausladen; Uwe Schirmer; Anne-Katrine Bonde; Glen Kristiansen; Martin L Sos; Walter Weder; Holger Moch; Peter Altevogt; Alex Soltermann
Journal:  Mol Cancer       Date:  2011-10-10       Impact factor: 27.401

View more
  13 in total

1.  Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma.

Authors:  Y Zhang; L F Wang; J H Gao; L Li; P Jiang; X Lv; L X Yu; J Yang; R T Li; B R Liu
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

Review 2.  Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.

Authors:  Biagio Ricciuti; Clelia Mencaroni; Luca Paglialunga; Francesco Paciullo; Lucio Crinò; Rita Chiari; Giulio Metro
Journal:  Med Oncol       Date:  2016-01-19       Impact factor: 3.064

Review 3.  Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients.

Authors:  Denisa Baci; Elona Cekani; Andrea Imperatori; Domenico Ribatti; Lorenzo Mortara
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

4.  Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.

Authors:  Ming Sun; Xiang-Hua Liu; Ke-Ming Wang; Feng-qi Nie; Rong Kong; Jin-song Yang; Rui Xia; Tong-Peng Xu; Fei-Yan Jin; Zhi-Jun Liu; Jin-fei Chen; Er-Bao Zhang; Wei De; Zhao-Xia Wang
Journal:  Mol Cancer       Date:  2014-03-21       Impact factor: 27.401

Review 5.  Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets.

Authors:  Jing Chen; Rui Wang; Kai Zhang; Long-Bang Chen
Journal:  J Cell Mol Med       Date:  2014-10-09       Impact factor: 5.310

6.  Up-regulation of long non-coding RNA XLOC_010235 regulates epithelial-to-mesenchymal transition to promote metastasis by associating with Snail1 in gastric cancer.

Authors:  Yu-Yi Liu; Ze-Hong Chen; Jian-Jun Peng; Jia-Lin Wu; Yu-Jie Yuan; Er-Tao Zhai; Shi-Rong Cai; Yu-Long He; Wu Song
Journal:  Sci Rep       Date:  2017-05-26       Impact factor: 4.379

7.  Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.

Authors:  Wu-Ping Wang; Ying Sun; Qiang Lu; Jin-Bo Zhao; Xue-Jiao Wang; Zhao Chen; Yun-Feng Ni; Ju-Zheng Wang; Yong Han; Zhi-Pei Zhang; Xiao-Long Yan; Xiao-Fei Li
Journal:  Oncotarget       Date:  2017-01-24

8.  EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.

Authors:  M Sun; X-H Liu; K-H Lu; F-Q Nie; R Xia; R Kong; J-S Yang; T-P Xu; Y-W Liu; Y-F Zou; B-B Lu; R Yin; E-B Zhang; L Xu; W De; Z-X Wang
Journal:  Cell Death Dis       Date:  2014-06-26       Impact factor: 8.469

9.  The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.

Authors:  Xiang-hua Liu; Zhi-li Liu; Ming Sun; Jing Liu; Zhao-xia Wang; Wei De
Journal:  BMC Cancer       Date:  2013-10-08       Impact factor: 4.430

10.  TFIIB-related factor 2 is associated with poor prognosis of nonsmall cell lung cancer patients through promoting tumor epithelial-mesenchymal transition.

Authors:  Yu Tian; Ming Lu; Weiming Yue; Lin Li; Shuhai Li; Cun Gao; Libo Si; Lei Qi; Wensi Hu; Hui Tian
Journal:  Biomed Res Int       Date:  2014-03-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.